Pharmabiz20h
Acelyrin to present positive results from global phase 3 trial of izokibep in hidradenitis suppurativa at EADV 2024
Acelyrin to present positive results from global phase 3 trial of izokibep in hidradenitis suppurativa at EADV 2024: Los Angeles Saturday, September 21, 2024, 18:00 Hrs [IST] Acel ...
Pharmabiz21h
ANGLE signs agreement with Recursion Pharma to expand pharma services business
ANGLE signs agreement with Recursion Pharma to expand pharma services business: London Saturday, September 21, 2024, 17:00 Hrs [IST] ANGLE plc, a world-leading liquid biopsy compa ...
Pharmabiz23h
EMA committee recommends Novo Nordisk’s Wegovy label update to reflect reduced heart failure symptoms and improved physical function
Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...
Pharmabiz22h
NIH-led studies point to potential development of a cataract drug
NIH-led studies point to potential development of a cataract drug: Bethesda, Maryland Saturday, September 21, 2024, 16:00 Hrs [IST] Researchers at the National Institutes of Healt ...